T1	Participants 485 527	newly diagnosed patients with osteosarcoma
T2	Participants 550 748	Six hundred sixty-two patients with osteosarcoma without clinically detectable metastatic disease and whose disease was considered resectable received one of four prospectively randomized treatments
